These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3744726)

  • 1. Suprathreshold responses of the visual system in normals and in demyelinating diseases.
    Medjbeur S; Tulunay-Keesey U
    Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1368-78. PubMed ID: 3744726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
    Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
    Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spatial contrast sensitivity in multiple sclerosis].
    Vighetto A; Grochowicki M; Cousin J
    Rev Neurol (Paris); 1990; 146(4):264-70. PubMed ID: 2359900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suprathreshold vision in acute optic neuritis.
    Sjöstrand J; Abrahamsson M
    J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):227-34. PubMed ID: 7086443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suprathreshold contrast matching in maculopathy.
    Mei M; Leat SJ
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3419-24. PubMed ID: 17591917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraliminal contrast sensitivity functions in recovered optic neuritis.
    Tagami Y; Isayama Y; Masumi K; Bo H
    Jpn J Ophthalmol; 1982; 26(2):205-12. PubMed ID: 7131929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
    Alshuaib WB
    Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast sensitivity loss in multiple sclerosis. Selectivity by eye, orientation, and spatial frequency measured with the evoked potential.
    Kupersmith MJ; Seiple WH; Nelson JI; Carr RE
    Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):632-9. PubMed ID: 6724832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal responses of the visual system in demyelinating diseases.
    Medjbeur S; Tulunay-Keesey U
    Brain; 1985 Mar; 108 ( Pt 1)():123-38. PubMed ID: 3978395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial contrast sensitivity in patients with multiple sclerosis.
    Carter R; Danta G
    Clin Exp Neurol; 1985; 21():233-47. PubMed ID: 3843223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
    Flanagan P; Zele AJ
    Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual-evoked response, pattern electroretinogram, and psychophysical magnocellular thresholds in glaucoma, optic atrophy, and dyslexia.
    Vaegan ; Hollows FC
    Optom Vis Sci; 2006 Jul; 83(7):486-98. PubMed ID: 16840873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
    Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
    Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of vision and pupil responses in optic neuritis and multiple sclerosis.
    Moro SI; Rodriguez-Carmona ML; Frost EC; Plant GT; Barbur JL
    Ophthalmic Physiol Opt; 2007 Sep; 27(5):451-60. PubMed ID: 17718884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
    Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
    Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early clinical evaluation of visual function in patients with age-related cataract].
    Fu J; Wang J; Wang NL; Kang HJ
    Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):236-40. PubMed ID: 16643756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset.
    Yeh EA; Weinstock-Guttman B; Lincoff N; Reynolds J; Weinstock A; Madurai N; Agarwal N; Buch P; Karpinski M; Ramanathan M
    Mult Scler; 2009 Jul; 15(7):802-10. PubMed ID: 19465453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
    Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
    J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.
    Sisto D; Trojano M; Vetrugno M; Trabucco T; Iliceto G; Sborgia C
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1264-8. PubMed ID: 15790888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.